文献速递胸部技术与安全PETCT

基于机器学习的治疗前18F-FDG PET/CT诊断方法评估非小细胞肺癌纵隔淋巴结

Machine learning-based diagnostic method of pre-therapeutic 18F-FDG PET/CT for evaluating mediastinal lymph nodes in non-small cell lung cancer.
PubMed 文献 · Eur Radiol · 2020-11-25

本研究回顾1329枚纵隔淋巴结,比较五种机器学习模型与核医学医师对非小细胞肺癌纵隔淋巴结转移的诊断效能。仅用定量变量的机器学习模型与医师准确率无显著差异(79.8% vs 76.8%,p=0.067),加入临床信息后准确率显著高于医师(81.0% vs 76.8%,p=0.009),在低18F-FDG摄取淋巴结中机器学习准确率亦显著更高(70.0% vs 63.3%,p=0.018)。

要点

  • 加入临床信息的机器学习模型诊断准确率显著高于核医学医师(81.0% vs 76.8%,p=0.009)。
  • 仅用定量变量的机器学习模型与医师准确率无显著差异(79.8% vs 76.8%,p=0.067)。
  • 低18F-FDG摄取纵隔淋巴结中机器学习准确率显著高于医师(70.0% vs 63.3%,p=0.018)。

核心结论

  • 仅用定量变量的机器学习模型与医师诊断准确率无显著差异,而加入临床信息后机器学习模型诊断效能优于仅用定量变量模型或医师。
  • 机器学习方法似乎有助于评估低代谢纵隔淋巴结,在18F-FDG PET/CT定量变量基础上加入临床信息可改善机器学习诊断结果。

研究设计与样本

  • 回顾性分析1329枚纵隔淋巴结,比较提升决策树、逻辑回归、支持向量机、神经网络和决策森林五种机器学习模型。
  • 将最佳机器学习模型与核医学医师诊断效能进行比较,并将机器学习方法分为仅用定量变量(MLq)和加入临床信息(MLc)两类。
  • 基于纵隔淋巴结18F-FDG摄取程度进行分析。

关键影像表现/征象

  • 提升决策树模型获得最高的曲线下面积值。
  • 提升决策树模型较核医学医师具有更高的敏感度和阴性预测值,但特异度和阳性预测值较低。

诊断标准与关键数值

  • 医师与MLq准确率分别为76.8%和79.8%,两者无显著差异(p=0.067)。
  • MLc准确率为81.0%,显著高于医师的76.8%(p=0.009)。
  • 在低18F-FDG摄取纵隔淋巴结中,机器学习准确率为70.0%,显著高于医师的63.3%(p=0.018)。

临床应用与阅片要点

  • 在18F-FDG PET/CT定量变量基础上加入临床信息,可提高机器学习模型对纵隔淋巴结转移的诊断准确率。
  • 机器学习方法似乎有助于评估低18F-FDG摄取纵隔淋巴结。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to find the best machine learning (ML) model using 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for evaluating metastatic mediastinal lymph nodes (MedLNs) in non-small cell lung cancer, and compare the diagnostic results with those of nuclear medicine physicians.

METHODS: A total of 1329 MedLNs were reviewed. Boosted decision tree, logistic regression, support vector machine, neural network, and decision forest models were compared. The diagnostic performance of the best ML model was compared with that of physicians. The ML method was divided into ML with quantitative variables only (MLq) and adding clinical information (MLc). We performed an analysis based on the 18F-FDG-avidity of the MedLNs.

RESULTS: The boosted decision tree model obtained higher sensitivity and negative predictive values but lower specificity and positive predictive values than the physicians. There was no significant difference between the accuracy of the physicians and MLq (79.8% vs. 76.8%, p = 0.067). The accuracy of MLc was significantly higher than that of the physicians (81.0% vs. 76.8%, p = 0.009). In MedLNs with low 18F-FDG-avidity, ML had significantly higher accuracy than the physicians (70.0% vs. 63.3%, p = 0.018).

CONCLUSION: Although there was no significant difference in accuracy between the MLq and physicians, the diagnostic performance of MLc was better than that of MLq or of the physicians. The ML method appeared to be useful for evaluating low metabolic MedLNs. Therefore, adding clinical information to the quantitative variables from 18F-FDG PET/CT can improve the diagnostic results of ML.

KEY POINTS: • Machine learning using two-class boosted decision tree model revealed the highest value of area under curve, and it showed higher sensitivity and negative predictive values but lower specificity and positive predictive values than nuclear medicine physicians. • The diagnostic results from machine learning method after adding clinical information to the quantitative variables improved accuracy significantly than nuclear medicine physicians. • Machine learning could improve the diagnostic significance of metastatic mediastinal lymph nodes, especially in mediastinal lymph nodes with low 18F-FDG-avidity.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yoo J, Cheon M, Park YJ, et al. Machine learning-based diagnostic method of pre-therapeutic 18F-FDG PET/CT for evaluating mediastinal lymph nodes in non-small cell lung cancer. Eur Radiol. 2020. PMID: 33241521. doi:10.1007/s00330-020-07523-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。